Ambria Dermatology Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$42.3M
Ambria Dermatology General Information
Description
Developer of a patented delivery platform. The company's delivery platform is based on pentane-1,5-diol, for improving dermal delivery of topically applied pharmaceuticals.
Contact Information
Corporate Office
- Kullagatan 8-10
- 252 20 Helsingborg
- Sweden
Corporate Office
- Kullagatan 8-10
- 252 20 Helsingborg
- Sweden
Ambria Dermatology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 11-May-2009 | $42.3M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | 20-Nov-2006 | $707K | $707K | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2001 | Completed | Startup |
Ambria Dermatology Patents
Ambria Dermatology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2558252-T3 | Antimicrobial composition | Active | 07-Jul-2008 | ||
| CA-2729944-A1 | Antimicrobial composition | Active | 07-Jul-2008 | ||
| US-20120004314-A1 | Antimicrobial composition | Inactive | 07-Jul-2008 | ||
| EP-2312952-A1 | Antimicrobial composition | Active | 07-Jul-2008 | ||
| EP-2312952-B1 | Antimicrobial composition | Active | 07-Jul-2008 | A01N31/02 |
Ambria Dermatology Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aqilion | Corporation | Minority | ||
| Chalmers Ventures | Venture Capital | Minority | ||
| Innovationsbron | Venture Capital | Minority |
Ambria Dermatology FAQs
-
When was Ambria Dermatology founded?
Ambria Dermatology was founded in 2001.
-
Where is Ambria Dermatology headquartered?
Ambria Dermatology is headquartered in Helsingborg, Sweden.
-
What industry is Ambria Dermatology in?
Ambria Dermatology’s primary industry is Drug Delivery.
-
Is Ambria Dermatology a private or public company?
Ambria Dermatology is a Private company.
-
What is the current valuation of Ambria Dermatology?
The current valuation of Ambria Dermatology is .
-
What is Ambria Dermatology’s current revenue?
The current revenue for Ambria Dermatology is .
-
How much funding has Ambria Dermatology raised over time?
Ambria Dermatology has raised $707K.
-
Who are Ambria Dermatology’s investors?
Aqilion, Chalmers Ventures, and Innovationsbron have invested in Ambria Dermatology.
-
When was Ambria Dermatology acquired?
Ambria Dermatology was acquired on 11-May-2009.
-
Who acquired Ambria Dermatology?
Ambria Dermatology was acquired by Natumin Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
